Companies: 10,795·Total market cap: $144.5T
Amplifon S.p.A.

Amplifon S.p.A.

AMFPFOTCHealthcare● Active
$12.01
+$0.00(+0.00%)
Market Cap$2.6B
P/E Ratio—
52W High$23.85
52W Low$9.46
Cash on HandFinancialsRevenue

Amplifon S.p.A. (AMFPF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

AMFPF · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$308.8M▲ +6.9% vs prior year
FY · as of Dec 31, 2025 · Reported in EUR
Cash & Cash Equiv. (CCE)
$308.8M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+6.9%
vs prior fiscal year
Latest Quarter
$310.7M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in EUR

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$308.8MCash on Hand
Total Debt$1.53BTotal Debt
Net Cash / Net Debt−$1.22BNet Debt Position
Cash vs Debt Ratio
Cash 17%Debt 83%

Amplifon S.p.A. carries a net debt position of $1.22B. Total debt ($1.53B) exceeds cash on hand ($308.8M). Amplifon S.p.A. cash vs debt ratio: 17% cash / 83% debt.

Net Cash = Cash & ST Investments − Total Debt$308.8M − $1.53B = −$1.22B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
AMFPF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$308.8M+6.9%
Dec 31, 2024$288.9M+48.9%
Dec 31, 2023$194.0M-15.5%
Dec 31, 2022$229.6M-27.9%
Dec 31, 2021$318.4M-42.5%
AMFPF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Amplifon S.p.A.
Amplifon S.p.A.YOU
AMFPF
$308.8M11.7%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Amplifon S.p.A. (AMFPF) cash on hand as of December 31, 2025 is $308.8M, comprising $308.8M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Amplifon S.p.A. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Amplifon S.p.A. cash reserves or cash position.

Amplifon S.p.A. annual cash on hand history shows increased +6.9% in 2025: increased +6.9% in 2025. Amplifon S.p.A. cash reserves in 2025 reflect the company's capital allocation strategy.

Amplifon S.p.A. carries total debt of $1.53B against cash of $308.8M, resulting in a net debt position of -$1.22B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

AMFPF cash on hand · 5 questions

As of December 31, 2025, Amplifon S.p.A. (AMFPF) has $308,766,310 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $308,766,310 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $310,730,383. Data sourced from the annual 10-K filing via FMP.

AMFPF cash on handAMFPF cash reservesAMFPF cash 2025how much cash does AMFPF have

▸ Source: FMP /balance-sheet-statement · US GAAP · Amplifon S.p.A. · Amplifon S.p.A. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025